User login
Management of cancer-related pain
Article Type
Changed
Fri, 01/04/2019 - 11:12
Display Headline
Management of cancer-related pain
In the article by Cipta and colleagues1 reviewing cancer-related pain management, after discussing cancer pain syndromes and their many sources, they turn their attention to the assessment and management of those cancer-related pains. However, there is no mention of breakthrough pain in cancer patients (BTCP) either in regard to assessment or management, including the use of transmucosal fentanyl for its treatment. Their discussion of pain assessment highlights the need to obtain a detailed pain history from the patient that includes intensity, quality, and aggravating factors of the cancer-related pain.
Click on the PDF icon at the top of this introduction to read the full article.
Article PDF
Issue
The Journal of Community and Supportive Oncology - 14(3)
Topics
Page Number
130-131
Legacy Keywords
cancer-related pain, pain management, fentanyl, breakthrough pain in cancer patients, BTCP
Sections
Article PDF
Article PDF
In the article by Cipta and colleagues1 reviewing cancer-related pain management, after discussing cancer pain syndromes and their many sources, they turn their attention to the assessment and management of those cancer-related pains. However, there is no mention of breakthrough pain in cancer patients (BTCP) either in regard to assessment or management, including the use of transmucosal fentanyl for its treatment. Their discussion of pain assessment highlights the need to obtain a detailed pain history from the patient that includes intensity, quality, and aggravating factors of the cancer-related pain.
Click on the PDF icon at the top of this introduction to read the full article.
In the article by Cipta and colleagues1 reviewing cancer-related pain management, after discussing cancer pain syndromes and their many sources, they turn their attention to the assessment and management of those cancer-related pains. However, there is no mention of breakthrough pain in cancer patients (BTCP) either in regard to assessment or management, including the use of transmucosal fentanyl for its treatment. Their discussion of pain assessment highlights the need to obtain a detailed pain history from the patient that includes intensity, quality, and aggravating factors of the cancer-related pain.
Click on the PDF icon at the top of this introduction to read the full article.
Issue
The Journal of Community and Supportive Oncology - 14(3)
Issue
The Journal of Community and Supportive Oncology - 14(3)
Page Number
130-131
Page Number
130-131
Topics
Article Type
Display Headline
Management of cancer-related pain
Display Headline
Management of cancer-related pain
Legacy Keywords
cancer-related pain, pain management, fentanyl, breakthrough pain in cancer patients, BTCP
Legacy Keywords
cancer-related pain, pain management, fentanyl, breakthrough pain in cancer patients, BTCP
Sections
Citation Override
JCSO 2016;14:130-131
Disallow All Ads
Alternative CME
Article PDF Media
Document